Please turn JavaScript on
header-image

CNBC - Business


Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  27.18 / week

Message History

Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.


Read full story

Men’s makeup is shedding stigma as TikTok and Gen Z drives growth, retailers rethink displays and brands chase one of beauty’s last untapped markets.


Read full story

The decision is an about-face for the automaker, which has touted its sales leadership of the models, known as PHEVs, for years.


Read full story

Eligible customers with insurance can pay as little as $25 for a one-month supply of the drug, while cash-paying options start at $149 a month, Amazon said.


Read full story

Strong market returns and the AI boom have meant new riches for some employees, but it's risky to have too much of your net worth tied up in one stock.


Read full story